Jochen D Muehlschlegel1, Danos C Christodoulou, David McKean, Joshua Gorham, Erica Mazaika, Mahyar Heydarpour, Grace Lee, Steven R DePalma, Tjorvi E Perry, Amanda A Fox, Stanton K Shernan, Christine E Seidman, Sary F Aranki, Jon G Seidman, Simon C Body. 1. From the Brigham and Women's Hospital, Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Boston, Massachusetts (J.D.M., M.H., S.K.S., S.C.B.); Department of Genetics, Harvard Medical School, Boston, Massachusetts (D.C.C., D.M., J.G., E.M., S.R.D., J.G.S.); Harvard Medical School, Boston, Massachusetts (G.L.); Northwest Anesthesia, Abbott Northwestern Hospital and Minneapolis Heart Institute, Minneapolis, Minnesota (T.E.P.); Department of Anesthesiology, University of Texas Southwestern Medical Center, Dallas, Texas (A.A.F.); Howard Hughes Medical Institute, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (C.E.S.); and Brigham and Women's Hospital, Division of Cardiac Surgery, Department of Surgery, Harvard Medical School, Boston, Massachusetts (S.F.A.).
Abstract
BACKGROUND: The exact mechanisms that underlie the pathological processes of myocardial ischemia in humans are unclear. Cardiopulmonary bypass with cardioplegic arrest allows the authors to examine the whole transcriptional profile of human left ventricular myocardium at baseline and after exposure to cold cardioplegia-induced ischemia as a human ischemia model. METHODS: The authors obtained biopsies from 45 patients undergoing aortic valve replacement surgery at baseline and after an average of 79 min of cold cardioplegic arrest. Samples were RNA sequenced and analyzed with the Partek Genomics Suite (Partek Inc., St. Louis, MO) for differential expression. Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA) and Biobase ExPlain (Biobase GmbH, Wolfenbuettel, Germany) systems were used for functional and pathway analyses. RESULTS: Of the 4,098 genes with a mean expression value greater than 5, 90% were down-regulated and 9.1% were up-regulated. Of those, 1,241 were significantly differentially expressed. Gene ontology analysis revealed significant down-regulation in immune inflammatory response and complement activation categories and highly consistent was the down-regulation of intelectin 1, proteoglycan, and secretory leukocyte peptidase inhibitor. Up-regulated genes of interest were FBJ murine osteosarcoma viral oncogene homolog and the hemoglobin genes hemoglobin α1 (HBA1) and hemoglobin β. In addition, analysis of transcription factor-binding sites revealed interesting targets in factors regulating reactive oxygen species production, apoptosis, immunity, cytokine production, and inflammatory response. CONCLUSIONS: The authors have shown that the human left ventricle exhibits significant changes in gene expression in response to cold cardioplegia-induced ischemia during cardiopulmonary bypass, which provides great insight into the pathophysiology of ventricular ischemia, and thus, may help guide efforts to reduce myocardial damage during surgery.
BACKGROUND: The exact mechanisms that underlie the pathological processes of myocardial ischemia in humans are unclear. Cardiopulmonary bypass with cardioplegic arrest allows the authors to examine the whole transcriptional profile of human left ventricular myocardium at baseline and after exposure to cold cardioplegia-induced ischemia as a humanischemia model. METHODS: The authors obtained biopsies from 45 patients undergoing aortic valve replacement surgery at baseline and after an average of 79 min of cold cardioplegic arrest. Samples were RNA sequenced and analyzed with the Partek Genomics Suite (Partek Inc., St. Louis, MO) for differential expression. Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA) and Biobase ExPlain (Biobase GmbH, Wolfenbuettel, Germany) systems were used for functional and pathway analyses. RESULTS: Of the 4,098 genes with a mean expression value greater than 5, 90% were down-regulated and 9.1% were up-regulated. Of those, 1,241 were significantly differentially expressed. Gene ontology analysis revealed significant down-regulation in immune inflammatory response and complement activation categories and highly consistent was the down-regulation of intelectin 1, proteoglycan, and secretory leukocyte peptidase inhibitor. Up-regulated genes of interest were FBJ murineosteosarcoma viral oncogene homolog and the hemoglobin genes hemoglobin α1 (HBA1) and hemoglobin β. In addition, analysis of transcription factor-binding sites revealed interesting targets in factors regulating reactive oxygen species production, apoptosis, immunity, cytokine production, and inflammatory response. CONCLUSIONS: The authors have shown that the human left ventricle exhibits significant changes in gene expression in response to cold cardioplegia-induced ischemia during cardiopulmonary bypass, which provides great insight into the pathophysiology of ventricular ischemia, and thus, may help guide efforts to reduce myocardial damage during surgery.
Authors: Kirsten A Kortekaas; Pieter van der Pol; Jan H N Lindeman; Carla C Baan; Cees van Kooten; Robert J M Klautz Journal: Eur J Cardiothorac Surg Date: 2012-03-09 Impact factor: 4.191
Authors: Cole Trapnell; Adam Roberts; Loyal Goff; Geo Pertea; Daehwan Kim; David R Kelley; Harold Pimentel; Steven L Salzberg; John L Rinn; Lior Pachter Journal: Nat Protoc Date: 2012-03-01 Impact factor: 13.491
Authors: Heon Goo Lee; Hiroshi Minematsu; Kyung Ok Kim; Ayse B Celil Aydemir; Mike J Shin; Saqib A Nizami; Kook Jin Chung; Anny C Hsu; Christopher R Jacobs; Francis Youngin Lee Journal: Biomaterials Date: 2011-09-06 Impact factor: 12.479
Authors: Marcela Silva Oliveira; Fabio Carmona; Walter V A Vicente; Paulo H Manso; Karina M Mata; Mara Rúbia Celes; Erica C Campos; Simone G Ramos Journal: Pediatr Cardiol Date: 2017-02-18 Impact factor: 1.655
Authors: Mahyar Heydarpour; Julius Ejiofor; Michael Gilfeather; Gregory Stone; Josh Gorham; Christine E Seidman; Jon G Seidman; Maroun Yammine; Simon C Body; Sary F Aranki; Jochen D Muehlschlegel Journal: Ann Thorac Surg Date: 2018-07-17 Impact factor: 4.330
Authors: Louis A Saddic; Martin I Sigurdsson; Tzuu-Wang Chang; Erica Mazaika; Mahyar Heydarpour; Stanton K Shernan; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Jochen D Muehlschlegel Journal: Circ Cardiovasc Genet Date: 2017-01
Authors: Susan R Scott; Keith L March; I-Wen Wang; Kanhaiya Singh; Jianyun Liu; Mark Turrentine; Chandan K Sen; Meijing Wang Journal: J Mol Cell Cardiol Date: 2021-11-11 Impact factor: 5.000
Authors: Gregory Stone; Ashley Choi; Oliva Meritxell; Joshua Gorham; Mahyar Heydarpour; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Vincent J Carey; Benjamin A Raby; Barbara E Stranger; Jochen D Muehlschlegel Journal: Hum Mol Genet Date: 2019-05-15 Impact factor: 6.150
Authors: Martin I Sigurdsson; Louis Saddic; Mahyar Heydarpour; Tzuu-Wang Chang; Prem Shekar; Sary Aranki; Gregory S Couper; Stanton K Shernan; Jon G Seidman; Simon C Body; Jochen D Muehlschlegel Journal: Genome Med Date: 2016-12-06 Impact factor: 11.117
Authors: David M McKean; Jason Homsy; Hiroko Wakimoto; Neil Patel; Joshua Gorham; Steven R DePalma; James S Ware; Samir Zaidi; Wenji Ma; Nihir Patel; Richard P Lifton; Wendy K Chung; Richard Kim; Yufeng Shen; Martina Brueckner; Elizabeth Goldmuntz; Andrew J Sharp; Christine E Seidman; Bruce D Gelb; J G Seidman Journal: Nat Commun Date: 2016-09-27 Impact factor: 14.919